Atrial Fibrillation Trial, Recruiting NCT06005233 Sponsor: Technical University of Munich Condition: Atrial Fibrillation
Back to Atrial Fibrillation

Atrial Fibrillation Trial, Recruiting

NCT06005233
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have had a small heart monitor (called an implantable loop recorder with remote monitoring) surgically placed under their skin to track heart rhythms.
  • People who have had a stroke within the last six months that doctors could not find a clear cause for, after a full medical workup — including brain scans, checks of the blood vessels, and heart monitoring over at least 24–72 hours — that ruled out common stroke causes such as blocked arteries, blood clots in the heart, irregular heart rhythms, and other specific conditions.
  • People who have had a type of mini-stroke (called a TIA) within the last six months that caused specific symptoms such as difficulty speaking, ignoring one side of the body, or loss of vision on one side, and where no clear cause was found after a full standard evaluation.
  • People aged 40 years or older.
  • People who have at least one of the following risk factors: a heart risk score (called CHA2DS2VASc) of 4 or higher; short bursts of fast heart rhythm detected on monitoring; a left chamber of the heart measuring more than 45mm; or very slow blood flow out of a part of the heart called the left atrial appendage (confirm with trial site for exact measurements).
  • People who have no medical reason preventing them from taking blood-thinning medication following the acute phase of their stroke.
  • People who have given written consent to participate, either themselves or through an authorised caregiver.

Who may not be able to join:

  • People who are unable to record a single-lead ECG reading using a smartwatch.
  • People who do not own a smartphone running iOS version 10.0 or later, or an Android device.
  • People who already have an implanted pacemaker or implanted heart defibrillator (ICD).
  • People who are pregnant or currently breastfeeding.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 0049(0)8941404606

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Technical University of Munich
Registry
ClinicalTrials.gov
Start date
15 October 2024
Est. completion
1 March 2026

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

Sensitivity and Specificity of AFib Detection

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov